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Abstract 
(R)-1-Benzyloxycarbonyl-2-(4-methoxyphenyl)methyl-3-pyrroline 14 was synthesized from 
(S)-N, O-dibenzyl malimide 5 via a highly regio and trans stereoselective reductive alkylation of 
5. This constitutes an improved formal asymmetric synthesis of natural (-)-anisomycin. 
 





Polysubstituted pyrrolidines represent a class of bioactive natural products as exemplified by the 
















      (-)-Anisomycin 1      (+)-Preussin 2         (-)-Codonopsinine 3 
 
Since its first isolation from Streptomyces griseolus and S. roseochromogenes1 in the early 
fifties of last century, anisomycin has become an important tool in molecular biology.2 It also has 
been used for the treatment of trichomonas vaginitis3 and amebic dysentery,4 and as an 
agricultural fungicide.5 More recently, it was reported that anisomycin showed high in vitro 
antitumor activity,6 and could be used in a synergistic fashion with a cyclin-dependent protein 
kinase inhibitor to kill carcinoma cells.7 Consequently, many approaches have been developed 
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for the asymmetric synthesis of anisomycin.8 In continuation of our   efforts on the 
development  of amalic acid-based methodology to bioactive N-containing compounds,9 we 
have communicated an asymmetric approach to (-)-anisomycin.10 In that approach, the key 
reductive alkylation of 4 led to 9 in modest regioselectivity. We would like to report herein an 
improved formal asymmetric synthesis to (-)-anisomycin, which featured the reductive alkylation 
of  (S)-N,O-dibenzyl malimide 5 in high regio- and stereo-selectivity. 
 
 
Results and Discussion 
 
The synthesis began with the reductive alkylation of (S)-N,O-dibenzyl malimide 5 (Scheme 1), 
which was prepared starting from (S)-malic acid as described previously. Thus, the addition of 
p-methoxybenzylmagnesium chloride to 5 led smoothly to the desired α-hydroxylactam 6 as a 
diastereomeric mixture and in high regioselectivity, which was deduced in the followed step. The 
stereochemistry of the isomeric 6 was not assigned. This diastereomeric mixture, although 
separable by flash chromatography, was used in the next step as it was, since the followed Lewis 
acid mediated ionic hydrogenation11 was considered to proceed by the intermediacy of the 
N-acyliminium 7.9,12 Indeed, in the presence of 3.0 equivalents of boron trifluoride etherate, 
hydroxylactams 6 were reduced with excess of triethylsilane (CH2Cl2, -78°C~ r.t.) to yield 
predominantly trans-8 in 94.8% yield. The coupling constant of ~0 Hz for H-4/H-5 in 8 indicates 
a trans orientation9 of these two protons, was later confirmed by converting 8 to known 
(R)-(-)-14 8e,f,i.  
Catalytic hydrogenation (10% Pd/C, H2,1atm) of 8 afforded 9 in quantitative yield. 
4-Hydroxypyrrolidinone 9 was reduced to pyrrolidine 10 (LiAlH4, THF, reflux) in 90% yield. 
N-Debenzylation in the presence of Pearman’s catalyst (H2, Pd(OH)2/C, EtOH, r.t.) followed by 
selective N-benzyloxycarbonylation (CbzCl, NEt3, CH2Cl2, 0 °C → room temperature) gave 
N-protected pyrrolidine 12 in an overall yield of 77 %. Xanthation of alcohol 12 then provided 
13 in 72% yield. Upon thermolysis of 13 at 190°C under reduced pressure, the desired 
(R)-3-pyrroline 14 {[α]D20 –214 (c 1.18, CHCl3). lit. [[α]D20 +1.4 ( e.e. = 90%) for (S)-14;8h [α]D 
-190.4 (c 1.0, CHCl3);8l [α]D25 -199 (c 1.17, CHCl3);8m [α]D20 –135.7 (c 0.76, CHCl3),10 for 
(R)-14]} was obtained in 87.3% yield, of which the spectroscopic data fully matched those 
reported in the literature6m.  
Since (+)-14 has been converted into unnatural enantiomer (+)-anisomycin 18h,l,m, the present 
work constitutes a new formal asymmetric synthesis of the natural enantiomer of this antibiotic. 
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Scheme 1. Reagents and conditions: i) p-MeOC6H4CH2MgCl, THF, -15 °C ~ -10 °C, 94.5 %; ii) 
BF3 •OEt2, Et3SiH, -78 °C, 94.8 %; iii) H2, 1 atm, 10 % Pd/C, EtOH, 100 %; iv) LiAlH4, THF, 
reflux, 90 %; v) H2, 1atm, 20 % Pd(OH)2/C, EtOH, r.t.; vi) CbzCl, Et3N, CH2Cl2, r.t., 77 % 
over two steps; vii) NaH, THF, imidazole, 65 °C; CS2, 60 °C; MeI, 60 °C, 72 %; viii) neat, 190 





General Procedures. Melting points were determined on a Yanaco MP-500 micro melting point 
apparatus. Infrared spectra were measured with a Shimadza  IR-408 spectrometer or a Nicolet 
Avatar 360 FT-IR spectrometer using film KBr pellet techniques. 1H-NMR spectra were recorded 
in CDCl3 on a Varian unity +500 spectrometer with tetramethylsilane as an internal standard. 
Chemical shifts are expressed in δ (ppm) units downfield from TMS. Mass spectra were recorded 
by Finnigan Mat-LCQ (ESI direct injection). Optical rotations were measured with Perkin-Elmer 
341 automatic polarimeter. THF and diethyl ether used in the reactions were dried by distillation 
over metallic sodium and benzophenone; dichloromethane were distilled over P2O5. Silica gel 
(Zhifu, 300~400 mesh) was used for column chromatography, eluting (unless otherwise stated) 
with ethyl acetate/petroleum ether (PE) (60-90°C) mixtures. 
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(S)-1-Benzyl-4-benzyloxy-5-(4-methoxybenzyl)-2-pyrrolidinone (8). To a stirred cold solution 
of (S)-O-Benzyloxy malimide9a (2.5 g, 8.47 mmol) in THF (15 mL) at –15 oC was added 
dropwise a 1.0 M solution of freshly prepared 4-methoxybenzylmagnesium chloride in THF (15 
mL, 15 mmol) under an atmosphere of N2. The mixture was stirred at –10 ~ -15 °C for 1 hour 
and then quenched by adding a saturated aqueous solution of NH4Cl (15 mL) and water (10 mL) 
at –10 °C. After diluted by dichloromethane (100 mL) the mixture was poured into a separatory 
funnel. The orgnic layer were separated, and the aqueous phase was extracted with CH2Cl2 (3×25 
mL). The combined organic phase was washed with brine, dried with anhydrous Na2SO4. After 
flash chromatographic purification (eluent: ethyl acetate: petroleum ether = 1:2), a white solid 
(3.34 g, 94.5%) were obtained which is a mixture of two diastereisoomers. This diastereomeric 
mixture (2.92 g, 7.0 mmol) was dissolved in dry dichloromethane (28 mL), and cooled to -78 °C. 
Et3SiH (11.2 mL, 70 mmol) and BF3•OEt2 (2.6 mL, 21 mmol) were successively added. The 
resulting mixture was stirred at -78 °C for 6 hours, and then allowed to rise to room temperature. 
After stirred at room temperature for 6 hours the mixture was quenched by adding a saturated 
solution of NaHCO3 (8 mL) at 0 °C. After diluted by dichloromethane (50 mL), the mixture was 
poured into a separatory funnel. The orgnic layer were separeted. The aqueous phase was 
extracted with CH2Cl2 (3×10 mL). The combined organic phase was washed with brine, and 
dried with anhydrous Na2SO4. After flash chromatographic purification (eluent: ethyl acetate: 
petroleum ether = 1:1.5), pyrrolidinone 8 was obtained as a colorless oil (2.66 g, 94.8 %). [α]D20 
25.6 (c 0.6, CHCl3). IR (film) νmax: 3050, 2930, 2850, 1687, 1614, 1512, 1444, 1302, 1250, 1175, 
1070, 1030, 820, 735, 695 cm-1. 1H-NMR (500 Mz, CDCl3) δ: 2.45 (m, 2H, H-3), 2.51 (dd, J= 
8.48, 13.94 Hz, 1H, H-6), 2.86 (dd, J= 4.52, 13.94 Hz, 1H, H-6), 3.68 (dd, J= 4.52, 8.48 Hz, 1H, 
H-5), 3.80 (s, 3H, OCH3), 3.85 (dd, J= 2.07, 4.83 Hz, 1H, H-4), 3.96 (d, J= 15.20 Hz, 1H, 
NCH2Ph), 4.11(d, J= 11.90 Hz, 1H, OCH2Ph), 4.16 (d, J= 11.90 Hz, 1H, OCH2Ph), 5.16 (d, J= 
15.20 Hz, 1H, NCH2Ph), 6.80-7.40 (4m, 14H, Ph-H) ppm; 13C-NMR (125 Mz, CDCl3) δ: 36.08 
(1C), 37.10 (1C), 44.27 (1C), 55.28 (1C), 64.11 (1C), 70.07 (1C), 74.80 (1C), 114.20 (2×Ar–CH), 
127.56 (3×Ar–CH), 127.66 (1×Ar–CH), 127.93 (3×Ar–CH), 128.33 (2×Ar–CH), 128.73 
(2×Ar–CH), 130.18 (2× Ar–CH), 136.17 (1× Ar–CH), 137.44 (1×Ar–CH), 158.60 (1×Ar–CH), 
173.07 (C=O) ppm. MS (EI): 401 (M+, 2.5), 280 (29), 254 ( 11), 91 (100). HRMS calcd for 
[C26H27O3N]+ 401.1991, found 401.1983. 
(S)-1-Benzyl-4-hydroxy-5-(4-methoxybenzyl)-2-pyrrolidinone (9).  To a mixture of 8  800 
mg, 2 mmol) and 10 % Pd-C (170 mg) was added ethanol (10 mL). The mixture was stirred at 
room temperature and under an atmosphere of H2 for 7 days. The mixture was filtered over celite. 
Flash chromatographic purification on silica gel (eluent: ethyl acetate: petroleum ether = 2 : 1) 
provided pyrrolidinone 9 as a colorless oil (620 mg, 100%). [α]D20 + 4.80 (c 1.0, CHCl3). IR 
(film) νmax: 3350, 2820, 1660, 1510, 1450, 1250, 1175, 1025, 690 cm-1. 1H-NMR (500 Mz, 
CDCl3) δ: 2.27 (dd, J= 1.07, 17.50 Hz, 1H, H-3), 2.45 (dd, J= 6.14, 17.50 Hz, 1H, H-3), 2.55 (dd, 
J= 7.98, 14.05 Hz, 1H, H-6), 2.86 (dd, J= 4.76, 14.05 Hz, 1H, H-6), 3.50 (dd, J= 4.76, 7.98 Hz, 
1H, H-5), 3.78 (s, 3H, OCH3), 3.93 (d, J= 15.20 Hz, 1H, NCH2Ph), 4.16 (s, 1H, H-4), 5.12 (d, J= 
15.20 Hz, 1H, NCH2Ph), 6.80- 7.40 (m, 9H, Ph-H) ppm; 13C-NMR (125 Mz, CDCl3) δ: 36.05 
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(1C), 39.59 (1C), 44.30 (1C), 55.28 (1C), 67.06 (1C), 68.96 (1C), 114.30 (2×Ar–CH), 127.65 
(1×Ar–CH), 128.03 (2×Ar–CH), 128.17 (1×Ar–CH), 128.78 (2×Ar–CH), 130.11 (2× Ar–CH), 
136.16 (1×Ar–CH), 158.65 (1×Ar–CH), 172.88 (C=O) ppm. MS (EI): 311 (M+, 3.2), 293 (M-18, 
43.5), 190 (83.1), 91(100), 57 (99); HRMS calcd for [C19H19NO2 (M+-H2O)] 293.1416, found 
293.1413. 
(S)-1-Benzyl-3-hydroxy-2-(4-methoxybenzyl)-pyrrolidine (10).  To a ice-cooled suspension 
of LAH (230 mg, 4.5 mmol) in anhydrous THF (3.0 mL) , was added, under an atmosphere of N2, 
a solution of 9 (430 mg, 1.38 mmol) in THF (4 mL). After stirred at room temperature for 2 
hours, then at 50 oC for 4 hours, the mixture was cooled with a ice-bath, then wet diethyl ether (6 
mL), 10% solution of sodium hydroxide (107 mL) and water (0.3 mL) were added successively. 
The mixture was allowed to reach room temperature, stirred for 30 min, and filtered through 
celite. After concentrated under reduced pressure, the residue was purified by flash 
chromatography on silica gel ( eluent: ethyl acetate: petroleum ether : NH3 aq. = 2 : 1 : 0.01). The 
pyrrolidine 10 (382 mg , yield, 93%) was abtained as a colorless oil. [α]D20 -54.3 (c 1.0, CHCl3). 
IR (film) νmax: 3450, 2850, 1610, 1510, 1450, 1245, 1175, 1025, 690 cm-1. 1H-NMR (500 Mz, 
CDCl3 ) δ: 1.61 (m, 1H, H-4), 1.99 (m, 1H, H-4), 2.48-2.58 (m, 2H, H-5, H-6), 2.65 (m, 1H, H-5), 
2.87 (m, 1H, H-2), 2.95 (dd, J= 4.45, 13.51 Hz, 1H, H-6), 3.46 (d, J= 13.00 Hz, 1H, NCH2Ph), 
3.78 (s, 3H, OCH3), 4.02 (d, J= 13.00 Hz, 1H, NCH2Ph ), 4.08 (m, 1H, H-3), 6.80-7.40 (m, 9H, 
Ph-H) ppm; 13C-NMR (125 Mz, CDCl3) δ: 32.34 (1C), 37.75 (1C), 51.49 (1C), 55.24 (1C), 58.86 
(1C), 74.05 (1C), 76.03 (1C), 114.01 (2×Ar–CH), 127.07 (1× Ar–CH), 128.30 (2×Ar–CH), 
129.01 (2×Ar–CH), 130.25 (2×Ar–CH), 130.85 (1×Ar–CH), 138.99 (1× Ar–CH), 158.11 
(1×Ar–CH) ppm. MS (EI): 297 (M+, 9), 279 (M+-H2O, 69), 277 (3.19), 176(100), 91(92.24); 
HRMS calcd for [C11H14NO (M+-p-CH3OC6H4CH2)] 176.1075, found 176.1072. 
(S)-1-Benzyloxycarbonyl-3-hydroxy-2-(4-methoxybenzyl)-pyrrolidine (12).  To a mixture of 
10 (460 mg, 1.55 mmol) and 10% Pd-C (187 mg) was added ethanol (8 mL). The mixture was 
stirred at room temperature and under an atmosphere of H2 for 15 hours. The mixture was 
filtered over celite, washed with ethyl acetate (1% NH3 aq.). After concentrated under reduced 
pressure, the crude pyrrolidine 11 was obtained as a yellow oil (300 mg, yield, 93.7%), which 
was used in the next step as it was. 
To an anhydrous CH2Cl2 (7 mL) solution of the crude pyrrolidine 11 and a catalytic amount 
of DMAP, was successively added Et3N (0.4 mL, 2.9 mmol) and CbzCl (0.6 mL, 1.25 mmol) 
dropwise at 0 oC and under an atmosphere of N2. The mixture was stirred at room temperature 
for 4 hours. After concentrated at reduced pressure, the residue was purified by flash 
chromatography on silica gel (eluent: ethyl acetate: petroleum ether = 1 : 1) affording 12 (409 
mg , yield, 82.8%) as a colorless oil. [α]D20 + 17.7 (c 1.1, CHCl3). IR (film) νmax: 3320, 2950, 
1675, 1510, 1410, 1360, 1248, 1105, 1030, 980, 690 cm-1. 1H-NMR (500 Mz, CDCl3 ) (show the 
peaks of two rotamers) δ: 1.75-1.95 (2m, 2H, H-4), 2.45 (m, 1H, H-2), 2.95, 3.12 (2dd, J= 3.30, 
13.66; 2.80, 13.66, 1H, H-6), 3.47, 3.61 (2m, 2H, H-5), 3.76, 3.78 (2s, 3H, OMe), 3.92, 3.93 
(2dd, J= 2.61, 13.66; 2.12, 13.66 Hz, 1H, H-6), 4.16 (s br, 1H, H-3), 5.10-5.22 (m, 2H, NCH2Ph), 
6.70-7.40 (m, 9H, Ph-H) ppm; 13C-NMR (125 Mz, CDCl3) (show the peaks of two rotamers) δ: 
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30.94, 31.49 (1C), 37.38, 38.43 (1C), 44.41, 44.65 (1C), 55.24 (C-3), 66.70, 67.10 (1C), 67.81, 
68.36 (1C), 73.46, 74.36 (1C), 113.99(2×Ar–CH), 127.83, 127.95 (1×Ar–CH), 128.06 
(2×Ar–CH), 128.50 (2×Ar–CH), 129.97 (2×Ar–CH), 130.14 (1×Ar–CH), 130.34 (2×Ar–CH), 
136.68, 136.93 (1×Ar–CH), 155.09 (1×Ar–CH), 158.28 (C=O) ppm. MS (EI): 341(M+, 6.09), 
220 (18.88), 176 (25.25), 121 (19.29), 91 (100); HRMS calcd for [C20H23NO4 ] 341.1627, found 
341.1628. 
( 2R, 3S ) – 1 - ( Benzyloxycarbonyl ) – 2 - ( 4-methoxybenzyl ) pyrrolidin – 3 - yl S-Methyl 
Xanthate (13).  To a suspension of NaH (170 mg, 50% in petrolatum, 3.53 mmol) and 
imidazole (75 mg) in anhydrous THF (2.0 mL), was added, under an atmosphere of N2, a 
solution of 12 (370 mg, 1.08 mmol) in THF (5 mL). After stirred at 60 oC for 2 hours, carbon 
disulfide (0.3 mL, 6 mmol) was added dropwise. The mixture was stirred at 60 oC for 4 hours. 
Then, methyl iodide (0.3 mL, 4.8 mmol) was added, and the mixture was refluxed for additional 
4 hours. The mixture was cooled with an ice-bath, then quenched by water (4 mL). The reaction 
mixture was extracted with ethyl acetate (3×10 mL). The combined organic phase was washed 
with brine, dried with anhydrous Na2SO4. After concentrated at reduced pressure, the residue was 
purified by flash chromatography on silica gel (eluent: ethyl acetate: petroleum ether = 1 : 5) to 
yield 13 (286 mg , yield, 72%) as a yellow oil. [α]D20 – 3.3 (c 1.5, CHCl3). IR (film) νmax: 2950, 
1700, 1510, 1410, 1345, 1250, 1210, 1100, 1040, 690 cm-1. 1H-NMR (500 Mz, CDCl3 ) (show 
the peaks of two rotamers) δ: 1.70 (m, 1H, H-4), 2.04 (m, 1H, H-4), 2.50 (s, 3H, S-CH3), 2.78, 
2.90 (2dd, J= 7.52, 13.82; 7.67, 13.82, 1H, H-6), 2.95, 3.07 (2dd, J= 3.68, 13.82; 3.15, 13.82 Hz, 
1H, H-6), 3.40- 3.62 (m, 2H, H-5 ), 3.77, 3.79 (2s, 3H, OMe), 4.22, 4.31 (2dd, J= 3.15, 3.68, 
7.52, 7.67 Hz, 1H, H-2), 5.16, 5.24 (2dd, J= 12.10, 12.59; 12.10, 12.59 Hz, 2H, NCH2Ph), 5.75 
(m, 1H, H-3), 6.70-7.40 (m, 9H, Ph-H) ppm; 13C-NMR (125 Mz, CDCl3 ) (show the peaks of two 
rotamers) δ: 19.06 (S-C), 28.41, 29.24 (1C), 36.35, 37.59 (1C), 44.85, 45.19 (1C), 55.23 (C-3), 
64.54, 64.96 (1C), 66.83, 67.23 (1C), 85.67, 86.42 (1C), 113.96, 113.99(2×Ar–CH), 127.85 
(1×Ar–CH), 128.06, 128.13 (2×Ar–CH), 128.54 (2×Ar–CH), 128.97, 129.16 (1×Ar–CH), 130.42, 
130.58 (2×Ar–CH ), 136.55, 136.86 (1×Ar–CH), 154.71, 154.82 (1×Ar–CH), 158.28 (C=O), 
214.75 (C=S) ppm. MS (EI): 431 (M+, 8.9), 323 (19.5), 310 (33.9), 159 (19.29), 91 (100). 
(R)-1-Benzyloxycarbonyl-2-(4-methoxybenzyl)-3-pyrroline (14). Neat 13 was heated to 190 ~ 
200 oC under reduced pressure (<10 mmHg) for 2 hours. The resulting residue was purified by 
flash chromatography on silica gel (eluent: ethyl acetate: petroleum ether = 1 : 8) affording 
pyrroline 14 (131 mg , yield, 87.3%) as a yellow solid. [α]D20 – 214 (c 1.18, CHCl3). lit. [α]D20 
+1.4 (e.e. = 90%) for (S)-14;8h [α]D -190.4 (c 1.0, CHCl3);8l [α]D25 -199 (c 1.17, CHCl3);8m [α]D20 
–135.7 (c 0.76, CHCl3),10 for (R)-14]. IR (film) νmax: 2900, 1700, 1610, 1510, 1410, 1360, 1320, 
1245, 1100, 1025, 690 cm-1. 1H-NMR (500 Mz, CDCl3) (show the peaks of two rotamers) δ: 2.78, 
2.90 (2dd, J= 7.98, 13.21; 8.06, 13.20, 1H, H-6), 3.02, 3.13 (2dd, J= 3.10, 13.20; 3.07, 13.21 Hz, 
1H, H-6), 3.76, 3.78 (2s, 3H, OMe), 3.80, 3.83 (2m, 1H, H-5), 4.14, 4.20 (2dm, 1H, H-5), 4.75, 
4.80 (2m, 1H, H-2), 5.20, 5.25 (2dd, J= 12.08, 12.51; 12.08, 12.51 Hz, 2H, NCH2Ph), 5.60-5.72 
(m, 1H, H-3), 6.70-7.50 (m, 9H, Ph-H ) ppm; 13C-NMR (125 Mz, CDCl3) (show the peaks of 
two rotamers) δ: 38.31, 39.73 (1C), 53.56, 53.99 (1C),  55.18 (C-3),  65.36, 65.87 (1C), 66.55, 
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67.06 (1C), 113.44, 113.54 (2×Ar–CH), 125.29, 125.53 (=CH), 127.86, 127.94 (1×Ar–CH), 
128.10, 128.16 (2×Ar–CH), 128.48, 128.57 (2×Ar–CH), 129.40, 129.49 (=CH)129.57, 129.63 
(1×Ar–CH), 130.59, 130.79 (2×Ar–CH), 136.78, 137.08 (1×Ar–CH), 154.41, 154.65 (1×Ar–CH), 
158.04, 158.11 (C=O) ppm. MS (EI): 323 (M+, 16.1), 219 (7.3), 202 (29.0), 158 (35.5), 
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